Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piboserod in Symptomatic Persistent Atrial Fibrillation
NCT00041496Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2001
- Primary completion
- Dec 2003
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of piboserod in Atrial fibrillation (AFib), sponsored by GSK. Started Nov 2001; status: completed.
02
Drugs
piboserod
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00041496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00041496.